Congestive Heart Failure (CHF) is a foremost health problem worldwide, touching 4.8 million U.S. patients and accounts for 978,000 or 5-10% of all hospitalizations. Some estimates show 550,000 new cases of CHF diagnosed each year in the United States alone. Currently, CHF accounts for 20% of all discharges in the over age 65 categories; with the aging demographic, this statistic is expected to increase significantly. Overall, the cost of treating CHF is very high -$38 billion annually in the U.S., representing 5.4% of total health care costs and involves many physician visits - at least 11 million ambulatory visits per year. The mortality rate for CHF is high, with one in five persons dying within 1 year, more than half of the CHF patients dying within 5 years, and sudden death occurring at a rate of six to nine times that of the general population. One in five of all discharged patients age 65 and older had CHF as a primary or secondary diagnosis (Congestive Heart Failure, 2011, p. 1).
Congestive heart failure is a progressive disease that causes weakening of the heart and cardiovascular system. It develops when the heart is unable to pump enough blood to meet the demands of the body’s other organs. CHF is a progressive disorder that not only affects the heart, but other organs such as the lungs, the kidneys (Congestive Heart Failure in the Elderly, 2009, p. 1). Congestive Heart Failure (CHF) is a very common disease among the elderly. Diagnosis may be challenging since distinctive signs are often absent or masked in older people. Though there is no cure for CHF, it can be managed well with lifestyle changes and treatment so many seniors return to a full life. The other problem is elderly patients with heart failure may have ot...
... middle of paper ...
...id=12&sid=fc441ead-7ff7-4af2-9a64-ae8c731a86f0%40sessionmgr12&bdata=JkF1dGhUeXBlPXVybCxjb29raWUsaXAsdWlkJnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=c8h&AN=2004170752
Saczynski, J. S., Darling, C. E., Spencer, F. A., Lessard, D., Gore, J. M., & Goldberg, R. J. (2009, September). Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: the Worcester Heart Failure Study. Journal of the American Geriatrics Society, 57, 1587-1594. Retrieved from http://web.ebscohost.com/ehost/detail?vid=12&hid=107&sid=fc441ead-7ff7-4af2-9a64-ae8c731a86f0%40sessionmgr12&bdata=JkF1dGhUeXBlPXVybCxjb29raWUsaXAsdWlkJnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=c8h&AN=2010400298
Wireless, Batteryless Implantable Medical Products. (2011). Retrieved from http://www.mems-issys.com/implantable.shtml?&lang=en_us&output=json
The aim of this report is to provide an overview of chronic heart failure, examining signs symptoms and treatment related to the case study, and the anatomy and physiology of the heart will be discussed, and the pathophysiology of chronic heart failure.
Takeda A, Taylor SJC, Taylor RS, Khan F, Krum H, Underwood M. (2012). Clinical service organisation for heart failure (Review). Cochrane Database of Systematic Reviews. Issue 9. Art. No.: CD002752. DOI: 10.1002/14651858.CD002752.pub3.
These mechanisms contribute to the signs and symptoms of heart failure. However, the manifestations are nonspecific and do...
The heart is the most important organ in the human body. The purpose of it is to pump oxygen and nutrient-rich blood to all parts of the body. It rarely occurs that the heart muscle become worn-out.. The threat to the heart’s normal function is in the diseases. (Landstinget i Värmland, 2008) In Sweden cardiovascular diseases are type of diseases which causes most deaths. 4 out of 10 people die in cardiovascular diseases and thousands die prematurely because of it. Today 12 percent of the Swedish population is suffering from cardiovascular diseases (Hjärt-Lungfonden, 2008) and today 40 000 of the Swedish population have a pacemaker. (CISIONWIRE, 2008) A treatment for a heart that is beating too slowly is receiving a pacemaker which keeps the heartbeat regular. (Hjärt-Lungfonden, 2008(2)
Congestive Heart Failure is when the heart's pumping power is weaker than normal. It does not mean the heart has stopped working. The blood moves through the heart and body at a slower rate, and pressure in the heart increases. This means; the heart cannot pump enough oxygen and nutrients to meet the body's needs. The chambers of the heart respond by stretching to hold more blood to pump through the body or by becoming more stiff and thickened. This only keeps the blood moving for a short while. The heart muscle walls weaken and are unable to pump as strongly. This makes the kidneys respond by causing the body to retain fluid and sodium. When the body builds up with fluids, it becomes congested. Many conditions can cause heart failure, and they are Coronary artery disease, Heart attack, Cardiomyopathy, and conditions that overwork the heart.
My clinical rotation for NURN 236 is unique in that all patients I care for at Union Memorial Hospital in Baltimore, Maryland have a diagnosis of heart failure (HF). HF occurs when the heart is unable to pump adequate blood supply, resulting in insufficient oxygen and nutrients to the tissues of the body (Smeltzer, Bare, Hinkle, and Cheever, 2012). Approximately 670,000 Americans are diagnosed with HF each year and is the most common hospital discharge diagnosis among the elderly (Simpson, 2014). Moreover, according to the Centers for Medicare and Medicaid Services (CMS), HF is the leading cause of 30-day hospital readmission followed by acute myocardial infarction (AMI) and pneumonia (medicare.gov|Hospital Compare, 2013). This information along with my weekly HF patient cohort prompted my curiosity regarding impacts of HF readmissions, factors of HF readmission, and to compare suggested evidence based practice with policies utilized at Union Memorial for reducing the 30-day readmission rate for HF.
It is essential to the human body that the heart pump sufficient nutrient rich blood to the body’s cells, because the body won’t be able to function normally otherwise. When a heart muscle is unable to pump enough blood through to meet the body’s regular demand it is characterized as heart failure. Heart failure can usually be treated through conventional heart therapies and symptom management strategies, however conventional therapies don’t work for all patients with heart failure, this is what is depicted as advanced heart failure or end-stage heart failure. In other words “End stage” heart failure is when the condition becomes so severe that all conventional treatments no longer work, the only treatment that works for end stage heart failure is to have a heart transplantation-surgery to remove a person's diseased heart and replace it with a healthy heart from a deceased donor. However there are two large encompassing problems with this treatment. The first problem is that the patient is subject to shortages in donor organ availability and thus possible further decompensation and potential death while awaiting transplantation. According to the American Heart Association, there are over 500,000 new cases of end-stage heart failure in the United States every year. With only 2200 donor hearts available every year nearly 20-30% of the patients who die while they await a transplant. The second problem with this mode of treatment is that not all patients qualify for heart transplantation. Patients who have another disease in addition to end-stage heart failure do not qualify for heart transplantation. The discrepancy between the clinical need for donor hearts and the total number of hearts available, as well as the lack of treatment o...
The best way to prevent heart failure is to minimize the risks that cause it and to control existing health problems that are related to the condition such as high blood pressure and diabetes. If a person does happen to have heart failure there are many medications and treatments that can help control the disease and help the patient continue to live as normal of a life as possible. After being discharged from the hospital Mr. Carver will have to be aware of his condition at all times and take the proper measures to keep himself healthy. He will have to make many life changes and continue to keep up on any appointments made to make sure his condition is under control. With the proper understanding and management of his disease, Mr. Carver will be in a good condition to resume his life as before.
Today, cardiovascular disease is “the number one killer in the United States and the developed world” (Sapolsky, 2004, p. 41). Coronary heart disease (CHD) is the most common form of cardiovascular disease, and is responsible for claiming an unreasonable amount of lives every year. CHD can begin to accumulate in young adults, but is prominently found in both men and women in their later adult lives. As a result of CHD, men typically experience heart attacks, whereas women present with chest pains, known as angina (Matthews, 2005).
Mcmurray, J. "Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice." HUG - Service de pharmacologie et toxicologie cliniques - Genève. The European Journal of Heart Failure, 5 July 2005. Web. 20 Mar. 2014.
left ventricular function and heart failure.” Clinical Investigative Medicine. 31.2 (2008): E90-E97. Web. 15 Feb. 2014.
Dilated cardiomyopathy accounts for approximately 15% of heart failure cases in the under 75s (“Chronic Heart Failure”). Patients with Dilated cardiomyopathy are usually unaware of the disease until they experience the signs and symptoms of heart failure or they develop an arrhythmia.
The aim of this scenario-based assignment is to discuss the therapeutic intervention in the care of a patient with Congestive Cardiac Failure (CCF). A brief summary of the patient’s medical history will be given while discussing one specific nursing problem in terms of heart rate/ rhythm. Also, an overview of aetiology will be given as well as pathophysiology in order to explain the rationale for treatment and monitoring. Relevant research relating to the literature will be utilised throughout in order to critically analyse the care provided for the patient and determine if the patient received evidence based up-to-date care. In accordance with the statement from the Nursing and Midwifery Council (2008) code of conduct regarding patient confidentiality, no personal details of the patient involved will be disclosed. Therefore, the patient will be identified as Mrs S.
... patients with heart failure: Impact on patients. American Journal of Critical Care, 20(6), 431-442.
The Dutch Heart Failure Knowledge Scale is the tool that will be utilized to assess knowledge retention. It is a 15-item questionnaire that can be self-administered. T...